The DOI matches its Crossref record.
Synthetic biology’s first malaria drug meets market resistance
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cited by
Sorted by citations
Choi, K. R., Jang, W. D., Yang, D., Cho, J. S., Park, D., & Lee, S. Y. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.01.003 · Cited by 579
Shen, Q., Zhang, L., Liao, Z., Wang, S., Yan, T., Shi, P., Liu, M., Fu, X., Pan, Q., Wang, Y., et al. (2018) · Molecular Plant · doi:10.1016/j.molp.2018.03.015 · Cited by 315
Integrated omics analysis of specialized metabolism in medicinal plants
Rai, A., Saito, K., & Yamazaki, M. (2017) · The Plant Journal · doi:10.1111/tpj.13485 · Cited by 303
Wasternack, C., & Strnad, M. (2017) · New Biotechnology · doi:10.1016/j.nbt.2017.09.007 · Cited by 249
Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook
Wawrosch, C., & Zotchev, S. B. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11539-w · Cited by 252
“However, the process was not viable because of the then lower price of plant-derived drug in the fluctuating artemisinin market (Peplow 2016).”
Background
Metadata
- Authors
- Peplow, M.
- Venue
- Nature
- Published
- 2016-02-23
- Volume
- 530
- Issue
- 7591
- Pages
- 389-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2284539118
- Cited by
- 143
- References
- 0
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 12 · 2023: 12 · 2022: 13 · 2021: 15 · 2020: 17 · 2019: 16 · 2018: 18 · 2017: 23 · 2016: 6
- Type
- other
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Social Sciences › Business, Management and Accounting › Management of Technology and Innovation › Biotechnology and Related Fields
- Keywords
- malaria drugs, recombinant yeast, synthetic biology, drug production, commercialization, market resistance
- MeSH terms
- Antimalarials, Humans, Malaria, Drug Costs, Crops, Agricultural, Artemisia annua, Artemisinins, Synthetic Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
